Invivo therapeutics announces publication of 12- and 24-month data for inspire 1.0 study in peer-reviewed neurosurgery

Cambridge, mass.--(business wire)--invivo therapeutics holdings corp. (nasdaq: nviv) today announced the publication of a peer-reviewed manuscript in neurosurgery describing the previously disclosed 12- and 24-month data from the company's single-arm inspire 1.0 study (invivo study of probable benefit of the neuro-spinal scaffold™ for safety and neurologic recovery in subjects with complete thoracic ais a spinal cord injury). the publication is titled “acute implantation of a bioresorbable poly
NVIV Ratings Summary
NVIV Quant Ranking